Product Dossier
VARENAPIX
Product Dossier for VARENAPIX (varenicline (as tartrate), Arrotex Pharmaceuticals). ARTG record, PBS listing, PBAC outcomes — compiled by arcimedes.
- Sponsor: Arrotex Pharmaceuticals
- Active ingredient: varenicline (as tartrate)
- Therapeutic area: Psychiatry
- Related brand: RHEMIX
- Same area: REXULTI
- Same area: NICORETTE
What it is
VARENAPIX is a varenicline (as tartrate) tablet medicine available in 0.5 mg and 1.0 mg strengths.
PBS listing
The 1 mg tablet strength is listed on the PBS with 2 items under streamlined restriction, with an ex-manufacturer price of A$53.46.
Regulatory history
VARENAPIX 1 mg tablets in bottle format were first listed on the ARTG on 17 November 2022. The blister pack formulations (both 1 mg and the composite 0.5 mg/1.0 mg pack) were first listed on 24 November 2022.